AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1625127 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole
Number of subjects: 100
Study 1625127 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin plus tobramycin
Number of subjects: 100
Study 1625127 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 100
Study 1625127 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotic
Number of subjects: 100
Study 6367096 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 82
Study 6367096 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 82
Study 6367096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 31262439 — intervention group
Group type: EXPERIMENTAL
Intervention: Various coping strategies for re-engaging in everyday life and physical activities
Number of subjects: 16
Study 28980482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management for base fractures
Number of subjects: 60
Study 28980482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management for shaft fractures
Number of subjects: 60
Study 28980482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management for neck fractures
Number of subjects: 60
Study 27713964 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol-enriched beverage (IEB) (2.0 g twice a day)
Number of subjects: 44
Study 27713964 — intervention group
Group type: COMPARATOR
Intervention: Sweetened beverage based on sucrose (SB)
Number of subjects: 44
Study 27713964 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol-enriched beverage (IEB)
Number of subjects: 44
Study 24567620 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 2061
Study 24567620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2061
Study 22959954 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowering dietary linoleic acid for 12 weeks
Number of subjects: 0
Study 22959954 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 20048099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral column lengthening with lateral plantar pain
Number of subjects: 10
Study 20048099 — intervention group
Group type: COMPARATOR
Intervention: Lateral column lengthening without lateral plantar pain
Number of subjects: 10
Study 18008121 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg droperidol intravenously
Number of subjects: 52
Study 18008121 — intervention group
Group type: COMPARATOR
Intervention: No droperidol
Number of subjects: 52
Study 15625214 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention
Number of subjects: 122
Study 15625214 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 122
Study 15625214 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention plus clomipramine
Number of subjects: 122
Study 15625214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 17459901 — intervention group
Group type: EXPERIMENTAL
Intervention: l‐NMMA 0.15 mg/kg
Number of subjects: 79
Study 17459901 — intervention group
Group type: EXPERIMENTAL
Intervention: l‐NMMA 0.5 mg/kg
Number of subjects: 79
Study 17459901 — intervention group
Group type: EXPERIMENTAL
Intervention: l‐NMMA 1.0 mg/kg
Number of subjects: 79
Study 17459901 — intervention group
Group type: EXPERIMENTAL
Intervention: l‐NMMA 1.5 mg/kg
Number of subjects: 79
Study 17459901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 11196401 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials in Dental Research (RCT‐Ds)
Number of subjects: 0
Study 11196401 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Trials in Dental Research
Number of subjects: 0
Study 11196401 — intervention group
Group type: COMPARATOR
Intervention: Randomized Controlled Trials in Medicine
Number of subjects: 0
Study 11196401 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analyses in Dental and Medical Research
Number of subjects: 0
Study 11196401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental Research Publications
Number of subjects: 0
Study 8853216 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg daily)
Number of subjects: 37
Study 8853216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (400 mg daily)
Number of subjects: 37
Study 8853216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 1535321 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide (40 micrograms)
Number of subjects: 12
Study 6090017 — intervention group
Group type: EXPERIMENTAL
Intervention: teniposide
Number of subjects: 82
Study 6090017 — intervention group
Group type: EXPERIMENTAL
Intervention: amsacrine
Number of subjects: 82
Study 6090017 — intervention group
Group type: EXPERIMENTAL
Intervention: zinostatin
Number of subjects: 82
Study 6090017 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 82
Study 6090017 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss, extensive disease, nonambulatory status
Number of subjects: 82
Study 31328463 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily until progression or unacceptable toxicity
Number of subjects: 54
Study 29140116 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive and numeric graphical risk information for a 2-cm renal tumor
Number of subjects: 299
Study 29140116 — intervention group
Group type: COMPARATOR
Intervention: Descriptive risk information only for a 2-cm renal tumor
Number of subjects: 299
Study 29140116 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeric risk information for a 2-cm renal tumor
Number of subjects: 299
Study 29140116 — intervention group
Group type: EXPERIMENTAL
Intervention: All risk information types
Number of subjects: 299
Study 27798543 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Employment (SE) + Compensatory Cognitive Training (CCT)
Number of subjects: 40
Study 25499342 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1005
Study 22541894 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily 75%/25% neutral protamine lispro/lispro mix
Number of subjects: 14
Study 22541894 — intervention group
Group type: COMPARATOR
Intervention: Once daily insulin glargine
Number of subjects: 14
Study 22541894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insulin regimens
Number of subjects: 14
Study 20598991 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in lumen area
Number of subjects: 207
Study 20598991 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in plaque area
Number of subjects: 207
Study 20598991 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 207
Study 20598991 — intervention group
Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 207
Study 18924019 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniaturised cardiopulmonary bypass circuit (group M)
Number of subjects: 60
Study 18924019 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass circuit (group C)
Number of subjects: 60
Study 15817864 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg vitamin C/d
Number of subjects: 120
Study 15817864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12219861 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood state in extraverts
Number of subjects: 4
Study 12219861 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral or negative mood state in introverts
Number of subjects: 4
Study 12219861 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait-consistent moods
Number of subjects: 4
Study 9873216 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol, thiazide, potassium citrate, potassium‐magnesium citrate
Number of subjects: 0
Study 9873216 — intervention group
Group type: COMPARATOR
Intervention: Conservative program (high fluid intake and dietary modification)
Number of subjects: 0
Study 8540507 — intervention group
Group type: EXPERIMENTAL
Intervention: ColoCARE Self‐Test pads
Number of subjects: 102
Study 8540507 — intervention group
Group type: COMPARATOR
Intervention: Hemoccult II SENSA
Number of subjects: 102
Study 8540507 — intervention group
Group type: EXPERIMENTAL
Intervention: ColoCARE
Number of subjects: 102
Study 30947913 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with everolimus-eluting stents
Number of subjects: 1905
Study 30947913 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1905
Study 30076613 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + Probiotic (Bifidobacterium animalis subsp. lactis HN019), n=20
Number of subjects: 41
Study 30076613 — intervention group
Group type: COMPARATOR
Intervention: SRP + Placebo, n=21
Number of subjects: 41
Study 27072080 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol management intervention
Number of subjects: 0
Study 27072080 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 25047649 — intervention group
Group type: EXPERIMENTAL
Intervention: Botnia clamp
Number of subjects: 22
Study 25047649 — intervention group
Group type: COMPARATOR
Intervention: SHEC
Number of subjects: 22
Study 25047649 — intervention group
Group type: EXPERIMENTAL
Intervention: IVGTT
Number of subjects: 22
Study 22724562 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritually based intervention
Number of subjects: 316
Study 22724562 — intervention group
Group type: COMPARATOR
Intervention: Nonspiritual comparison
Number of subjects: 316
Study 19057523 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg q.d.
Number of subjects: 469
Study 19057523 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 15 mg q.d.
Number of subjects: 469
Study 19057523 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg b.i.d.
Number of subjects: 469
Study 19057523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 17474540 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 15 mg/kg
Number of subjects: 67
Study 17474540 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol 30 mg/kg
Number of subjects: 67
Study 15151350 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized drinking feedback (PDF) delivered with a motivational interview (MI)
Number of subjects: 54
Study 15151350 — intervention group
Group type: COMPARATOR
Intervention: Personalized drinking feedback (PDF) without a motivational interview (MI)
Number of subjects: 54
Study 11209008 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg atorvastatin
Number of subjects: 30
Study 11209008 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg cerivastatin
Number of subjects: 30
Study 11209008 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 9842612 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging at 55% of age-adjusted maximum heart rate
Number of subjects: 91
Study 9842612 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging at 75% of age-adjusted maximum heart rate
Number of subjects: 91
Study 9842612 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging at 79% of age-adjusted maximum heart rate
Number of subjects: 91
Study 8124988 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intravenous zinc therapy
Number of subjects: 8
Study 8124988 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental intravenous zinc therapy
Number of subjects: 8
Study 2535873 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine with varicella vaccine
Number of subjects: 101
Study 2535873 — intervention group
Group type: COMPARATOR
Intervention: MMR vaccine with placebo
Number of subjects: 101
Study 2535873 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicella vaccine
Number of subjects: 101
Study 2535873 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 101
Study 790553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 128
Study 790553 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen 150 mg daily
Number of subjects: 128
Study 790553 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 100 mg daily
Number of subjects: 128
Study 31079993 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-guided TKA
Number of subjects: 318
Study 31079993 — intervention group
Group type: COMPARATOR
Intervention: Surgeon-guided TKA
Number of subjects: 318
Study 28501736 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based group therapy
Number of subjects: 0
Study 28501736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 0
Study 28501736 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25697420 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 20
Study 25697420 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 30 mg
Number of subjects: 20
Study 25697420 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 20
Study 25697420 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 10 mg
Number of subjects: 20
Study 22581848 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg Methylphenidate (MPH)
Number of subjects: 52
Study 22581848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 20836726 — intervention group
Group type: EXPERIMENTAL
Intervention: OC containing 35 μg ethinylestradiol plus 2 mg cyproterone acetate
Number of subjects: 45
Study 20836726 — intervention group
Group type: EXPERIMENTAL
Intervention: OC containing 30 μg ethinylestradiol plus 3 mg drospirenone
Number of subjects: 45
Study 20836726 — intervention group
Group type: COMPARATOR
Intervention: Metformin 850 mg × 2
Number of subjects: 45
Study 20836726 — intervention group
Group type: EXPERIMENTAL
Intervention: OC treatment (both groups A and B)
Number of subjects: 45
Study 19228496 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyHeme
Number of subjects: 714
Study 19228496 — intervention group
Group type: COMPARATOR
Intervention: Control (crystalloid)
Number of subjects: 714
Study 16680293 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo off‐line applicative (software for obtaining digitized image measurements)
Number of subjects: 56
Study 16680293 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (comparison group)
Number of subjects: 56
Study 12691695 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Services Research (HSR)
Number of subjects: 0
Study 12691695 — intervention group
Group type: COMPARATOR
Intervention: Institutional Quality Improvement (QI) initiatives
Number of subjects: 0
Study 10735697 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified reperfusion (normothermic reperfusate enhanced with glutamate and aspartate for 5 minutes before removal of the cross-clamp)
Number of subjects: 40
Study 10735697 — intervention group
Group type: COMPARATOR
Intervention: Control group (unmodified reperfusion)
Number of subjects: 40
Study 10735697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 8757208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily for 6 weeks
Number of subjects: 274
Study 8757208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 1374266 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (560 mg; n = 10)
Number of subjects: 20
Study 3880735 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesterolone
Number of subjects: 0
Study 3880735 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 29360672 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational Intervention (PEI)
Number of subjects: 40
Study 29360672 — intervention group
Group type: COMPARATOR
Intervention: Traditional pamphlet education (Control)
Number of subjects: 40
Study 27429724 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone ointment and zinc-containing mouthwash
Number of subjects: 20
Study 27429724 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone ointment alone
Number of subjects: 20
Study 25588397 — intervention group
Group type: EXPERIMENTAL
Intervention: New method of conduction anesthesia by blocking the infraorbital nerve along its entire length
Number of subjects: 0
Study 22795360 — intervention group
Group type: EXPERIMENTAL
Intervention: LLPR system (interactive video game-based rehabilitation) for lower limb muscle power training, 30-min training, twice a week for 6 weeks (12 sessions)
Number of subjects: 40
Study 22795360 — intervention group
Group type: COMPARATOR
Intervention: Control group performing slow speed STS movements and strengthening and balance exercises, same frequency and duration as exercise group
Number of subjects: 40
Study 22795360 — intervention group
Group type: EXPERIMENTAL
Intervention: LLPR system (exercise group)
Number of subjects: 40
Study 20155790 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of small RCTs
Number of subjects: 87
Study 20155790 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical RCTs
Number of subjects: 87
Study 20155790 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of small trials
Number of subjects: 87
Study 18312806 — intervention group
Group type: EXPERIMENTAL
Intervention: Five discussion group sessions focusing on healthful eating, physical activity, goal-setting, and social support.
Number of subjects: 200
Study 18312806 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 200
Study 16360432 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 shock waves per minute
Number of subjects: 170
Study 16360432 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 shock waves per minute
Number of subjects: 170
Study 16360432 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 shock waves per minute
Number of subjects: 170
Study 11956124 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid at 5 mg/m2
Number of subjects: 25
Study 11956124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9604997 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 tumor marker
Number of subjects: 80
Study 9604997 — intervention group
Group type: COMPARATOR
Intervention: Control group (77 patients without evidence of neoplasm)
Number of subjects: 80
Study 7697954 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg immediate-release alprazolam
Number of subjects: 14
Study 7697954 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg extended-release alprazolam
Number of subjects: 14
Study 7697954 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg extended-release alprazolam
Number of subjects: 14
Study 7697954 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release alprazolam (both doses)
Number of subjects: 14
Study 7697954 — intervention group
Group type: COMPARATOR
Intervention: Extended-release alprazolam (both doses)
Number of subjects: 14
Study 2497634 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 21
Study 2497634 — intervention group
Group type: COMPARATOR
Intervention: High-amylose cornstarch
Number of subjects: 21
Study 385023 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (600 mg/day)
Number of subjects: 10
Study 385023 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 10
Study 385023 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (Labetalol and Bendrofluazide)
Number of subjects: 10
Study 385023 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 10
Study 31703567 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 38
Study 31703567 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 38
Study 29040119 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomaterial-free cultured oral mucosal epithelial cell sheets (COMECs)
Number of subjects: 8
Study 29040119 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating keratoplasty after stabilization of COMEC transplant
Number of subjects: 8
Study 29040119 — intervention group
Group type: EXPERIMENTAL
Intervention: COMECs transplantation
Number of subjects: 8
Study 26932802 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide 4 mg on days 1 to 21 of a 28‐day cycle with weekly dexamethasone (arm B)
Number of subjects: 70
Study 26932802 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide, dexamethasone, and cyclophosphamide (PomCyDex) 400 mg orally on days 1, 8, and 15 (arm C)
Number of subjects: 70
Study 25709419 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training with virtual spatial navigation task (CCT) during bed rest
Number of subjects: 16
Study 25709419 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 16
Study 23134528 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole/antagonist protocol (mild stimulation)
Number of subjects: 60
Study 23134528 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist protocol (microdose flare)
Number of subjects: 60
Study 19756811 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased social support through volunteer visitors for dementia patients
Number of subjects: 84
Study 19756811 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study 18467673 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg)
Number of subjects: 89
Study 18467673 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (2 mg/kg)
Number of subjects: 89
Study 16814257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl-eicosapentanoate (EPA) 6 g/day
Number of subjects: 0
Study 16814257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14651548 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue brushing with a hard toothbrush wetted with 0.12% chlorhexidine gluconate
Number of subjects: 28
Study 14651548 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tongue cleaning)
Number of subjects: 28
Study 11517825 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (50 mmol Na/day)
Number of subjects: 13